2 big name ASX companies ready for a 'share price recovery': experts

If you are seeking shelter in reliable brands amid chaotic times, here is a pair of stocks that professional investors reckon are ripe for a rise.

| More on:
two chemists celebrate by jokingly clinking two containers of chemicals while they wear white laboratory coats and protective glasses in their lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In times of uncertainty, many find comfort in historically reliable names.

And who can blame investors? Australia has just been through seven consecutive rate rises, with four of those jumbo 50-basis point leaps.

For those looking for familiar names, here are two ASX shares tipped as a buy this week:

Ready to break out after going sideways for 2 years

When it comes to big names on the ASX, they don't come much bigger than CSL Limited (ASX: CSL).

Shares for this biotechnology giant had made many investors very wealthy for more than a quarter of a century until the COVID-19 pandemic hit.

Its lacklustre performance since then has caught the eye of Fairmont Equities managing director Michael Gable.

"The share price of this blood products company has been relatively flat in the past two years," Gable told The Bull.

"Because CSL is a growth stock, interest rate rises have kept a lid on the share price."

But with interest rate rises poised to slow or even cease in the new year, Gable feels like CSl shares have a fighting chance to return to glory.

"The recent acquisition of Vifor Pharma should add to CSL's earnings next year, and a topping out in interest rates should also assist a share price recovery."

His peers are in broad agreement, with 15 out of 18 analysts currently surveyed on CMC Markets rating CSL as a buy.

Cloud computing ain't going anywhere

Unlike CSL, data centre operator NextDC Ltd (ASX: NXT)'s shares went absolutely gangbusters once the coronavirus struck the world.

As the world utilised cloud computing at record levels to enable working from home, the stock price rocketed up about 80% during the 2020 calendar year.

However, the general sell-off of technology and growth shares in 2022 has struck its fortunes hard, with the stock down around 33% for the year.

Sequoia Wealth Management senior wealth manager Peter Day feels like that's opened up a buying opportunity.

"Data centre services revenue of $291 million in fiscal year 2022 rose 18% on the prior corresponding period," he said.

"Underlying EBITDA was up 26% to $169 million."

Despite the return to the office for many workers in the post-COVID era, the long-term outlook for cloud computing remains bright.

"Investment in cloud computing should remain robust," he said.

"We expect the company's earnings base to remain resilient in a potentially slowing economy."

Motley Fool contributor Tony Yoo has positions in CSL Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Investing Strategies

Two men laughing while bouncing on bouncy balls
Blue Chip Shares

I think these ASX blue chips shares are primed for a major rebound in 2026

2025 was not kind to these shares. Here's why things could be better next year.

Read more »

Man on computer looking at graphs
Cheap Shares

The ASX stocks I'd buy that nobody else wants

These beaten down stocks could be worth looking at. Let's see why.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Cheap Shares

2 ASX 200 shares with massive upside potential according to brokers

WiseTech and NextDC shares have pulled back in recent times, but brokers see meaningful upside from current levels.

Read more »

the australian flag lies alongside the united states flag on a flat surface.
Dividend Investing

Own VTS ETF? Here's your next dividend

Vanguard has announced the final distribution for VTS ETF investors.

Read more »

An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.
Dividend Investing

Beat low interest rates with these buy-rated ASX dividend stocks

Analysts expect these stocks to offer dividend yields that are better than bank interest rates.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Blue Chip Shares

Is now the time to buy Pro Medicus shares?

After a 13% pullback, Pro Medicus shares are back in focus. Is this weakness an opportunity?

Read more »

Man holding a calculator with Australian dollar notes, symbolising dividends.
Dividend Investing

Forget term deposits! I'd buy these two ASX shares instead

These businesses have very impressive dividend records.

Read more »

Hand of a woman carrying a bag of money, representing the concept of saving money or earning dividends.
Dividend Investing

Why experts say these growing ASX dividend shares are top buys for income

Analysts have good things to say about these income options.

Read more »